← Leaderboards
Ulrich Steidl
Albert Einstein College Of Medicine
$14,632,610
Attributed
$18,510,762
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.6M · FY2008–25$10M$7.5M$5M$2.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,514,733 · 12
By mechanism
R01$10,401,638 · 5
R35$4,594,192 · 1
P30$4,085,189 · 2
U01$1,282,560 · 1
P01$1,271,089 · 1
R00$739,530 · 1
Top collaborators
- Amit Verma9 shared
- Britta Will4 shared
- Hannes Erich Buelow3 shared
Most similar at Albert Einstein College Of Medicine
Same institution · by research overlap
- Britta Will$4,590,997
- Avital Mendelson$586,378
- Maria Marianovich$1,363,044
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularCellsStem CellsLeukemiaProgenitorPathway InteractionsGenetic TranscriptionMouse ModelMutationHematopoietic Stem CellsStemSamplingPathogenesisIn VivoRelapseTranscription FactorGeneticMediatingBaseGrowthDisease RemissionLeadRegulationDysmyelopoietic Syndromes
Grant awards (44)
Cancer Center Support Grant$4,003,971
P30 · FY2025 · CA · contact PI
Molecular and Cellular Regulation of Pre-Leukemic Stem Cells and their Therapeutic Targeting$1,005,807
R35 · FY2025 · CA · contact PI
Project 2: Microenvironmental and inflammatory mechanisms in MDM4-driven AML pathogenesis.$627,482
P01 · FY2025 · CA · contact PI
Molecular and Cellular Regulation of Pre-Leukemic Stem Cells and their Therapeutic Targeting$957,601
R35 · FY2024 · CA · contact PI
Project 2: Microenvironmental and inflammatory mechanisms in MDM4-driven AML pathogenesis.$643,607
P01 · FY2024 · CA · contact PI
Contribution of macrophages in the HSC niche$549,162
R01 · FY2024 · HL · contact PI
Molecular and Cellular Regulation of Pre-Leukemic Stem Cells and their Therapeutic Targeting$866,743
R35 · FY2023 · CA · contact PI
Contribution of macrophages in the HSC niche$560,369
R01 · FY2023 · HL · contact PI
Molecular and Cellular Regulation of Pre-Leukemic Stem Cells and their Therapeutic Targeting$987,840
R35 · FY2022 · CA · contact PI
Contribution of macrophages in the HSC niche$560,369
R01 · FY2022 · HL · contact PI
STAT3 inhibition as a therapeutic strategy against MDS stem cells$531,973
R01 · FY2022 · HL
Molecular and Cellular Regulation of Pre-Leukemic Stem Cells and their Therapeutic Targeting$776,201
R35 · FY2021 · CA · contact PI
Contribution of macrophages in the HSC niche$560,369
R01 · FY2021 · HL · contact PI
STAT3 inhibition as a therapeutic strategy against MDS stem cells$531,973
R01 · FY2021 · HL
Therapeutic targeting of MDS stem cells$528,896
R01 · FY2021 · HL
A Fluorescence-Based High-Throughput Platform for Glycotyping the Hematopoietic Cell Lineage$427,520
U01 · FY2021 · CA
Mechanisms of Formation and Progression of Preleukemic Stem Cells$397,371
R01 · FY2021 · CA · contact PI
Stem Cells, Differentiation and Cancer$27,226
P30 · FY2021 · CA · contact PI
STAT3 inhibition as a therapeutic strategy against MDS stem cells$531,973
R01 · FY2020 · HL
Therapeutic targeting of MDS stem cells$528,896
R01 · FY2020 · HL
Mechanisms of Formation and Progression of Preleukemic Stem Cells$440,147
R01 · FY2020 · CA · contact PI
A Fluorescence-Based High-Throughput Platform for Glycotyping the Hematopoietic Cell Lineage$427,520
U01 · FY2020 · CA
Stem Cells, Differentiation and Cancer$26,996
P30 · FY2020 · CA · contact PI
STAT3 inhibition as a therapeutic strategy against MDS stem cells$531,973
R01 · FY2019 · HL
Therapeutic targeting of MDS stem cells$528,896
R01 · FY2019 · HL
A Fluorescence-Based High-Throughput Platform for Glycotyping the Hematopoietic Cell Lineage$427,520
U01 · FY2019 · CA
Mechanisms of Formation and Progression of Preleukemic Stem Cells$385,453
R01 · FY2019 · CA · contact PI
Stem Cells, Differentiation and Cancer$26,996
P30 · FY2019 · CA · contact PI
Mechanisms of Formation and Progression of Preleukemic Stem Cells$385,218
R01 · FY2018 · CA · contact PI
Therapeutic targeting of MDS stem cells$359,976
R01 · FY2018 · HL
Therapeutic targeting of MDS stem cells$168,920
R01 · FY2018 · HL
Mechanisms of Formation and Progression of Preleukemic Stem Cells$12,153
R01 · FY2018 · CA · contact PI
Mechanisms of Formation and Progression of Preleukemic Stem Cells$397,371
R01 · FY2017 · CA · contact PI
Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia$384,194
R01 · FY2017 · CA · contact PI
Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia$148
R01 · FY2017 · CA · contact PI
Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia$384,342
R01 · FY2016 · CA · contact PI
Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia$206,321
R01 · FY2015 · CA · contact PI
Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia$178,021
R01 · FY2015 · CA · contact PI
Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia$372,812
R01 · FY2014 · CA · contact PI
Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia$384,342
R01 · FY2013 · CA · contact PI
Transcriptional regulation of leukemic stem cells in acute myeloid leukemia$241,530
R00 · FY2011 · CA · contact PI
Transcriptional regulation of leukemic stem cells in acute myeloid leukemia$249,000
R00 · FY2010 · CA · contact PI
Transcriptional regulation of leukemic stem cells in acute myeloid leukemia$249,000
R00 · FY2009 · CA · contact PI
Transcriptional regulation of leukemic stem cells in acute myeloid leukemia$140,535
K99 · FY2008 · CA · contact PI